MR-C-014

· MedRhythms, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MR-C-014, covering 2025-12-15 to 2025-12-15. Get the full timeline:

Most recent: Clinical Trial Update: Acceptability and Safety of MR-C-014 in Persons With Neuromyelitis Optica Spectrum Disorder [NA]